| 2024 |
Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls
10.1016/s2665-9913(23)00338-7
Authors: L. Ferguson, G. Molenberghs, G. Verbeke, K. Rahimi, S. Rao, I. McInnes, J. McMurray, N. Sattar, N. Conrad |
| 2018 |
GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)
10.1002/pds.4448
Authors: C. Rebordosa, E. Plana, J. Aguado, S. Thomas, E. Garcia-Gil, S. Perez-Gutthann, J. Castellsague |
| 2021 |
Glycemic Control, Diabetic Complications, and Risk of Dementia in Patients With Diabetes: Results From a Large U.K. Cohort Study
10.2337/dc20-2850
Authors: B. Zheng, B. Su, G. Price, I. Tzoulaki, S. Ahmadi-Abhari, L. Middleton |
| 2020 |
Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study
10.1007/s13300-020-00905-y
Authors: X. Peng, R. McCrimmon, L. Shepherd, A. Boss, R. Lubwama, T. Dex, N. Skolnik, L. Ji, A. Avogaro, L. Blonde |
| 2005 |
Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes
Authors: M. Cook, C. Girman, P. Stein, C. Alexander, R. Holman |
| 2018 |
Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
10.2337/dc18-0287
Authors: J. Critchley, I. Carey, T. Harris, S. DeWilde, F. Hosking, D. Cook |
| 2016 |
Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study
10.1007/s13300-016-0193-8
Authors: J. Wilding, C. Bailey, U. Rigney, B. Blak, W. Beekman, C. Emmas |
| 2019 |
Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus
10.1016/j.diabres.2019.107791
Authors: P. J, U. Rigney, B. Blak, S. Nolan, P. Fenici, J. Medina |
| 2022 |
Glycaemic variability and progression of chronic kidney disease in people with diabetes and comorbid kidney disease: Retrospective cohort study
10.1016/j.diabres.2022.110117
Authors: H. Habte-Asres, T. Murrells, D. Nitsch, D. Wheeler, A. Forbes |
| 2023 |
Glycaemic control and weight outcomes after adding or switching to biphasic insulin aspart 30/70 in people with type 2 diabetes mellitus previously treated with basal-bolus insulin in UK clinical practice
10.1111/dom.15278
Authors: M. Davies, A. Alibegovic, P. Kelkar, U. Braae, A. Jensen |
| 2019 |
Glucose, cholesterol and blood pressure in type II diabetes: A longitudinal observational study comparing patients with and without severe mental illness
10.1111/jpm.12546
Authors: R. Smith, L. Han, S. Ali, S. Prady, J. Taylor, T. Hughes, R. Ajjan, N. Siddiqi, T. Doran |
| 2015 |
Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study
10.1007/s00125-014-3473-8
Authors: E. Kontopantelis, D. Springate, D. Reeves, D. Ashcroft, M. Rutter, I. Buchan, T. Doran |
| 2015 |
Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer
10.1111/dom.12412
Authors: S. Holden, S. Jenkins-Jones, C. Morgan, G. Schernthaner, C. Currie |
| 2023 |
Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification
10.1111/dme.15200
Authors: C. Pollock, J. Sanchez, J. Carrero, S. Kumar, R. Pecoits-Filho, C. Lam, H. Chen, E. Kanda, M. Lainscak, D. Wheeler |
| 2012 |
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
10.1007/s00125-011-2390-3
Authors: T. van Staa, D. Patel, A. Gallagher, M. De Bruin |
| 2021 |
Glucose Control, Sulfonylureas, and Insulin Treatment in Elderly People With Type 2 Diabetes and Risk of Severe Hypoglycemia and Death: An Observational Study
10.2337/dc20-0876
Authors: S. Ling, F. Zaccardi, C. Lawson, S. Seidu, M. Davies, K. Khunti |
| 2018 |
Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study
10.1007/s13300-017-0359-z
Authors: C. Morgan, Q. Qiao, S. Grandy, K. Johnsson, S. Jenkins-Jones, S. Holden, C. Currie |
| 2022 |
Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20-59 Years in the United Kingdom's CPRD 1995-2015
10.2147/clep.s341048
Authors: O. Ayodele, H. Cabral, D. McManus, S. Jick |
| 2006 |
Glucocorticoid use, other associated factors, and the risk of tuberculosis
10.1002/art.21705
Authors: S. Jick, E. Lieberman, M. Rahman, H. Choi |
| 2020 |
Glucocorticoid use is associated with an increased risk of hypertension
10.1093/rheumatology/keaa209
Authors: R. Costello, B. Yimer, P. Roads, M. Jani, W. Dixon |
| 2020 |
Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
10.1136/bmjdrc-2020-001220
Authors: J. Wu, S. Mackie, M. Pujades-Rodriguez |
| 2022 |
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study
10.1093/aje/kwac021
Authors: R. Pradhan, E. Patorno, H. Tesfaye, S. Schneeweiss, H. Yin, J. Franklin, A. Pawar, C. Santella, O. H. Y. Yu, C. Renoux, L. Azoulay |
| 2016 |
Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink
10.1136/bmj.i5340
Authors: B. Hicks, H. Yin, O. Yu, M. Pollak, R. Platt, L. Azoulay |
| 2018 |
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy
10.2337/dc17-2280
Authors: A. Douros, K. Filion, H. Yin, O. Yu, M. Etminan, J. Udell, L. Azoulay |
| 2022 |
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes
10.2337/dc21-1953
Authors: R. Pradhan, H. Yin, O. Yu, L. Azoulay |
| 2015 |
Glitazone Treatment and Incidence of Parkinson\textquoterights Disease among People with Diabetes: A Retrospective Cohort Study
10.1371/journal.pmed.1001854
Authors: R. Brauer, K. Bhaskaran, N. Chaturvedi, D. Dexter, L. Smeeth, I. Douglas |
| 2017 |
Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink
10.1093/rheumatology/kew482
Authors: L. Li, T. Neogi, S. Jick |
| 2002 |
Geriatric drug therapy and healthcare utilization in the United kingdom
10.1345/aph.1A226
Authors: A. Kennerfalk, A. Ruigomez, M. Wallander, L. Wilhelmsen, S. Johansson |
| 2017 |
Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study
10.1007/s00198-016-3811-4
Authors: A. Shah, D. Prieto-Alhambra, S. Hawley, A. Delmestri, J. Lippett, C. Cooper, A. Judge, M. Javaid |
| 2019 |
Genome-wide association study of statin-induced myopathy in patients recruited using the UK clinical practice research datalink
10.1002/cpt.1557
Authors: D. Carr, B. Francis, A. Jorgensen, E. Zhang, H. Chinoy, S. Heckbert, J. Bis, J. Brody, J. Floyd, B. Psaty, M. Molokhia, M. Lapeyre-Mestre, A. Conforti, A. Alfirevic, T. Van Staa, M. Pirmohamed |
| 2011 |
Genital warts and cost of care in England
10.1136/sti.2010.048421
Authors: S. Desai, S. Wetten, S. Woodhall, L. Peters, G. Hughes, K. Soldan |
| 2020 |
Generating high-fidelity synthetic patient data for assessing machine learning healthcare software
10.1038/s41746-020-00353-9
Authors: A Tucker, Z Wang, Y Rotalinti, P Myles |
| 2018 |
Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population
10.1093/aje/kwx287
Authors: J. Hong, Jonsson Funk, R. LoCasale, S. Dempster, S. Cole, M. Webster-Clark, J. Edwards, T. Sturmer |
| 2014 |
General practice-recorded depression and antidepressant use in young people with newly diagnosed Type 1 diabetes: a cohort study using the Clinical Practice Research Datalink
10.1111/dme.12330
Authors: E. Morgan, C. Patterson, C. Cardwell |
| 2005 |
General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction
10.1136/hrt.2004.037457
Authors: L. Tata, J. West, C. Smith, P. Farrington, T. Card, L. Smeeth, R. Hubbard |
| 2017 |
Gender inequality in acute gastro-enteritis rates in England.
Authors: T. Verstraeten, T. Cattaert, G. Ferreira |
| 2020 |
Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study
10.2147/copd.s264580
Authors: J. Amegadzie, J. Gamble, J. Farrell, Z. Gao |
| 2017 |
Gender differences in COPD exacerbations: Analysis from the CPRD database
Authors: D. Stolz, K. Kostikas, E. Loefroth, R. Fogel, A. Clemens, F.S. Gutzwiller, V. Conti, H. Cao |
| 2001 |
Gender and drug treatment as determinants of mortality in a cohort of heart failure patients
Authors: A. Ruigomez, S. Johansson, M. Wallander, L. Rodriguez |
| 2018 |
Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK
10.1016/j.canep.2018.04.008
Authors: Rgpj de Jong, Pjhl Peeters, A. Burden, M. De Bruin, H. Haak, A. Masclee, F. de Vries, M. Janssen-Heijnen |
| 2018 |
Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study
10.1111/bcp.13660
Authors: M. Iwagami, L. Tomlinson, K. Mansfield, I. Douglas, L. Smeeth, D. Nitsch |
| 2005 |
Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice
10.1378/chest.128.1.85
Authors: A. Ruigomez, L. Rodriguez, M. Wallander, S. Johansson, M. Thomas, D. Price |
| 2008 |
Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look
10.1111/j.1365-2125.2008.03154.x
Authors: L. Opatrny, J. Delaney, S. Suissa |
| 1997 |
Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?
Authors: L. Rodriguez, A. Ruigomez |
| 2015 |
Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink
10.1016/j.joca.2014.12.022
Authors: D. Culliford, J. Maskell, A. Judge, C. Cooper, D. Prieto-Alhambra, N. Arden |
| 1992 |
Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom
10.1002/pds.2630010607
Authors: Hershel Jick, Barbara Terris, Laura Derby, Susan Jick |
| 2019 |
Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study
10.1186/s12885-019-6242-8
Authors: P. Liu, U. McMenamin, A. Spence, B. Johnston, H. Coleman, C. Cardwell |
| 2021 |
Full Mortality risk in patients with adrenal insufficiency using Prednisolone or Hydrocortisone: A Retrospective Cohort study
10.1210/clinem/dgab347
Authors: K. Ngaosuwan, D. Johnston, I. Godsland, J. Cox, A. Majeed, J. Quint, N. Oliver, S. Robinson |
| 1999 |
Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents
Authors: S. Jick, M. Stender, M. Myers |
| 2022 |
Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
10.1136/thorax-2022-219039
Authors: H. Whittaker, C. Nordon, A. Rubino, T. Morris, Y. Xu, E. de Nigris, H. Mullerova, J. Quint |
